SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-070515
Filing Date
2024-06-11
Accepted
2024-06-11 19:00:40
Documents
1
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2416928-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2416928-2_4seq1.xml 4 4226
  Complete submission text file 0001104659-24-070515.txt   5883
Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN 4 L2
Business Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN 4 L2 6504963552
MILLER MICHAEL PATRICK (Reporting) CIK: 0001236514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 241037112

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)